Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . September 5th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Complementary & Alternative Medicine - Garlic oil and DDB have a hepatoprotective effect while lowering plasma lipids
Hepatitis B Vaccine - HBV vaccine questionable in patients receiving lamividine post liver transplant
Hepatitis B Virus - Company announces end of patient dosing in HepeX-B hepatitis B phase II trial
Hepatitis C Virus - Donor age above 50 increases risk of recurrence after liver transplantation
Hepatitis C Virus - Further study of the adiponectin/insulin resistance/HCV infection triad needed
Autoimmune Disease - MICA-mimicking peptides show promise in explaining NKG2D-related autoimmunity
Cancer Therapy - Data advance knowledge in cancer therapy research
Cancer Therapy - U.S. NIH awards grant for preclinical development of Talotrexin in combo therapy
Collaborations - Canadian company establishes joint venture with Chinese pharmaceutical company
Finance - Biopharmaceutical firm reports loss of $0.11 per share
Finance - Company focused on transdermal science reports Q2 2005 results, business update
Proteomics - Researchers provide details of new studies and findings in the area of proteomics
Finance - Gene-based therapies company reports second quarter 2005 financial results
Finance - Pharma company reports second quarter 2005 results
Finance - Prestara maker reports Q2 revenues of $1.7M and a net loss of $2.9M
Finance - Vaccine maker reports second quarter revenue of $1.2 million
HIV/AIDS Therapy - Company updates development of fixed-dose regimen of Truvada and Sustiva
Hematology - Reports advance knowledge in hematology research
Virology - Reports advance knowledge in virology research
Hepatitis C Therapy - Health Canada approves study of celgosivir compound in HCV non-responders
Hepatitis C Virus - Discovery team advances nonnucleoside compound in preclinical development
Hepatitis C Virus - HCV structural proteins may interfere with lipid transport and liver metabolism
Hepatitis C Virus - HCV treatment causes changes in tear dynamics and changes on ocular surface
Hepatitis C Virus - Hepatitis C virus NS3 protein's modulating role may facilitate virus life cycle
Hepatitis C Virus - Researchers propose new method for HCV genotyping
Virology - Reports describe recent advances in virology research
Hepatitis C Virus - Tarvacin phase I hepatitis C virus trial initiated
Hepatitis Pathogenesis - Hepatitis B virus X protein up-regulates lymphotoxin-alpha expression
Hepatocellular Carcinoma - Percutaneous ethanol injection is safe and effective as first-line option
Influenza - Pharmaceutical company receives grant to test influenza drug candidate
Oncology - Recent studies add new data to oncology research
Proteomics - Recent findings in proteomics provide new insights
Virology - Studies add new findings to virology body of knowledge
Stem Cell Research - Fetal liver epithelial cells with high repopulation capacity characterized
Transplant Medicine - Studies advance knowledge in transplant medicine research
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
